Results 11 to 20 of about 4,624 (175)
Biosynthesis and biological action of pineal allopregnanolone [PDF]
The pineal gland transduces photoperiodic changes to the neuroendocrine system by rhythmic secretion of melatonin. We recently provided new evidence that the pineal gland is a major neurosteroidogenic organ and actively produces a variety of ...
Kazuyoshi eTsutsui, Shogo eHaraguchi
doaj +3 more sources
Allopregnanolone in postpartum depression: Role in pathophysiology and treatment
Postpartum depression (PPD) is a unique subtype of major depressive disorder and a substantial contributor to maternal morbidity and mortality. In addition to affecting the mother, PPD can have short- and long-term consequences for the infant and partner.
Samantha Meltzer-Brody, Stephen J. Kanes
doaj +3 more sources
Brexanolone, a First-In-Class Neurosteroid Medication: Mechanism of Action, Clinical, and Translational Science. [PDF]
ABSTRACT Given the increasing prevalence of postpartum depression (PPD) and the stigma associated with this condition, it is essential to address this significant health concern. Brexanolone is an FDA‐approved treatment for PPD that works by positive‐allosteric modulation of type A γ‐aminobutyric acid (GABAA) receptors.
Gayanova L +4 more
europepmc +2 more sources
Allopregnanolone in Postpartum Depression
Postpartum depression (PPD) is a debilitating psychiatric disorder characterized by a high worldwide prevalence and serious long-term negative outcomes for both mothers and children. The lack of a specific treatment and overreliance on pharmacotherapy with limited efficacy and delayed treatment response has constituted a complication in the management ...
Graziano Pinna +3 more
openaire +3 more sources
Author's Response: Allopregnanolone ...
Pearson Murphy, Beverley E. +1 more
openaire +2 more sources
Response to Durability of zuranolone in postpartum depression versus major depressive disorder. [PDF]
This article relates to Response to Durability of zuranolone in postpartum depression versus major depressive disorder.
Kato M +8 more
europepmc +2 more sources
Allopregnanolone: An overview on its synthesis and effects [PDF]
Abstract Allopregnanolone, a 3α,5α‐progesterone metabolite, acts as a potent allosteric modulator of the γ‐aminobutyric acid type A receptor. In the present review, the synthesis of this neuroactive steroid occurring in the nervous system is discussed with respect to physiological and pathological conditions.
Silvia Diviccaro +4 more
openaire +2 more sources
Allopregnanolone concentrations and premenstrual syndrome [PDF]
OBJECTIVE: To evaluate basal allopregnanolone and progesterone in both phases of the menstrual cycle in women suffering from premenstrual syndrome (PMS) and their response to a GnRH test. DESIGN: We selected 56 women (28 patients with PMS and 28 controls) aged between 18 and 32 years. Blood samples were drawn in both follicular and phases. Twenty-eight
Monteleone, P +7 more
openaire +6 more sources
Allopregnanolone and reproductive psychiatry: an overview [PDF]
Psychiatric symptoms that coincide with reproductive transitions are related to changes in sex steroids, but studies show that this relationship is governed by individual women's vulnerability to change rather than by differences in level. There is growing interest in the role of allopregnanolone (ALLO), a 3-α reduced metabolite of progesterone and a ...
Katherine, McEvoy, Lauren M, Osborne
openaire +2 more sources
Allopregnanolone: State of the art
Allopregnanolone, a neuroactive steroid derived from progesterone, is synthesized within the nervous tissue, by means of specific enzymes. Contrary to progesterone and its first metabolite dihydroprogesterone, allopregnanolone is able to interact with GABA-A receptor and not with the classical progesterone receptor.
R.C. Melcangi, G. C. Panzica
openaire +3 more sources

